Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients [Phase 4]
This Phase 4 open-label interventional trial assessed the efficacy and safety of an extemporaneously combined nebivolol and ramipril regimen…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Resistance Plus Aerobic Training Using Different Weekly Frequencies And Hypertension [NA]
Clinical trial update showing completion of a study evaluating resistance plus aerobic training at different weekly frequencies in people wi…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Etiological Classification-guided Individual Intervention in Primary Hypertension [NA]
Clinical trial update for Etiological Classification-guided Individual Intervention in Primary Hypertension; sponsored by Shanghai 10th Peop…
-
EMA approval · 2025-04-23EMA Authorised: Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG) (telmisartan) — Bayer AG
EMA authorised Kinzalmono, a telmisartan product, by Bayer AG for the treatment of hypertension.
-
EMA approval · 2025-04-23EMA Authorised: Pritor (telmisartan) — Bayer AG
The EMA authorised the marketing of Pritor (telmisartan) by Bayer AG for the treatment of hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Stretching vs Walking for Lowering Blood Pressure [NA]
A recruiting clinical trial at the University of Saskatchewan is comparing stretching versus walking to lower blood pressure in adults with …
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry [NA]
This clinical trial update describes an ongoing study at Changi General Hospital evaluating the use of urine mass spectrometry to address me…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)
HYIMPACT is a prospective observational trial evaluating nebivolol (Nebilet) for blood pressure control in hypertensive patients and is curr…
-
FDA approval · 2025-04-21FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Hydralazine hydrochloride (generic) from Heritage Pharmaceuticals (d/b/a Avet) to support co…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg [Phase 1]
Phase 1 safety and pharmacokinetics study of fixed-dose amlodipine 10 mg and candesartan 32 mg completed for hypertension.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study [NA]
A clinical trial is recruiting to evaluate the Corsano CardioWatch 287-2 for the treatment/monitoring of hypertension.
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing oral melatonin to nebulized dexmedetomidine as premedication to attenuate hemodynamic responses during …
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Deep Breathing Techniques (Pranayama) in Pregnancy [NA]
A completed clinical trial from Children's Mercy Hospital Kansas City evaluated pranayama (deep breathing) in pregnant individuals with hype…
-
FDA approval · 2025-04-17FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for olmesartan medoxomil from Jubilant Cadista Pharmaceuticals, approving the generic product under …
-
FDA approval · 2025-04-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for Nicardipine hydrochloride from Epic Pharma, LLC, under the ANDA process. This represents a s…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Effects of Whole Body Vibration and Resistance Exercise on Carotis Intima Media and Muscle Architecture in Hypertension [NA]
A completed clinical trial investigates how whole body vibration and resistance exercise affect carotid intima-media thickness and muscle ar…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Baroloop Multicenter Trial (Baroloop MCT) [NA]
The Baroloop Multicenter Trial (Baroloop MCT) by neuroloop GmbH is currently recruiting participants with hypertension resistant to conventi…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Evaluation of a Novel Self-Sampling Earwax Tool for Chronic Disease Biomarkers [TREARS STUDIES II]
This clinical trial update describes a study evaluating a novel self-sampling earwax tool for detecting chronic disease biomarkers. The stud…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Nutrition Apps in Occupational Healthcare (Pilot Study of the FOODNUTRI Project) [NA]
A pilot clinical trial under the FOODNUTRI project is evaluating nutrition apps in occupational healthcare and is currently enrolling by inv…
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for the extended-release form of diltiazem hydrochloride.
-
FDA approval · 2025-04-16FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
-
FDA label_change · 2025-04-16FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride by Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
A completed clinical trial assessing how well 24-hour urinary aldosterone performs as a diagnostic test for primary aldosteronism in hyperte…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Automatic and Conventional Methods of Hypertensive Patients Monitoring
A clinical trial is evaluating automatic versus conventional methods for monitoring patients with primary hypertension.